Markets:

Overview

News

Currencies

International

Treasuries

ImmuCell Corporation - Common Stock (NQ:ICCC)

10.61 -0.18 (-1.67%)

Delayed Quote Updated: 11:17 AM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ImmuCell Corporation - Common Stock

< Previous 1 2 Next >

ImmuCell (ICCC) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Product sales hit $7.2 million as market share climbed to 19% amid capacity expansion plans.

Via The Motley Fool

Topics Earnings

ImmuCell Reports Q2 2026 Results: Full Earnings Call Transcript ↗

August 14, 2026

ImmuCell (NASDAQ:ICCC) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive...

Via Benzinga

Topics Earnings

ImmuCell Q2 Earnings Call Highlights ↗

August 14, 2026

ImmuCell (NASDAQ:ICCC) reported higher second-quarter sales and earnings as domestic demand for its calf scours prevention products increased, while the company outlined plans to invest about $8...

Via MarketBeat

Topics Earnings

ImmuCell Q1 Earnings Call Highlights ↗

May 15, 2026

ImmuCell (NASDAQ:ICCC) reported a record first quarter of 2026, with management saying the company’s narrowed focus on its First Defense calf scours prevention portfolio helped drive its first-ever...

Via MarketBeat

Topics Earnings

The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell ↗

December 26, 2025

Via Stocktwits

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

ImmuCell (ICCC) Q1 2026 Earnings Transcript ↗

May 15, 2026

ImmuCell (ICCC) Q1 2026 Earnings Transcript

Via The Motley Fool

Regulatory Roadblock: ImmuCell Pivots to Core Growth After FDA Rejects Mastitis Treatment

December 24, 2025

In a significant strategic shift that marks the end of a multi-year regulatory odyssey, ImmuCell Corporation (Nasdaq: ICCC) announced late yesterday, December 23, 2025, that it has received another...

Via MarketMinute

ImmuCell Q2 Profit Jumps as Margins Rise ↗

August 15, 2025

Via The Motley Fool

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

ICCC Stock Earnings: ImmuCell Beats Revenue for Q2 2024 ↗

August 13, 2024

ICCC stock results show that ImmuCell beat on revenue for the second quarter of 2024.

Via InvestorPlace

ICCC Stock Earnings: ImmuCell Reported Results for Q1 2024 ↗

May 14, 2024

ImmuCell just reported results for the first quarter of 2024.

Via InvestorPlace

ImmuCell ICCC Q2 2025 Earnings Call Transcript ↗

August 15, 2025

Via The Motley Fool

Topics Earnings

ImmuCell Posts 18% Gain in Q2 ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 22, 2025

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 14, 2025

Via Benzinga

Top Stock Reports For Apple, Eli Lilly & Shopify ↗

February 14, 2025

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Eli Lilly and Co., and Shopify Inc., as well as a micro-cap stock ImmuCell Corp.

Via Talk Markets

Topics Stocks / Equities

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 04, 2025

Via Benzinga

PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday ↗

July 10, 2024

Via Benzinga

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 09, 2024

Via Benzinga

Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 12, 2023

Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday.

Via Benzinga

AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday ↗

July 12, 2023

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 14, 2022

Via Benzinga

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Earnings Scheduled For November 21, 2022 ↗

November 21, 2022

Companies Reporting Before The Bell • Zepp Health (NYSE:ZEPP) is expected to report quarterly earnings at $0.54 per share on revenue of $186.58 million.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ImmuCell Corporation - Common Stock (NQ:ICCC)

All News about ImmuCell Corporation - Common Stock

Starting at /week.